Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",orosomucoid 1 amount,blood alpha-1-acid glycoprotein amount,RS:0000229,DA.PVG.1AV1-(D4Rat63-D4Rat203),both,180 days to 120 days,10,,CMO:0001466,serum orosomucoid 1 level,,,,480,mg/l,,,MMO:0000439,radial immunodiffusion assay,,0.0,radial immunodiffusion assay,,,,squalene (200 ul) ,69768,squalene (200 ul) , 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",orosomucoid 1 amount,blood alpha-1-acid glycoprotein amount,RS:0000229,DA.PVG.1AV1-(D4Rat63-D4Rat203),both,180 days to 120 days,10,,CMO:0001466,serum orosomucoid 1 level,,,,660,mg/l,,,MMO:0000439,radial immunodiffusion assay,,0.0,radial immunodiffusion assay,,,,type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) ,69770,type II collagen (500 ug) ,Freund's incomplete adjuvant (100 ul) 1162,"Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.",orosomucoid 1 amount,blood alpha-1-acid glycoprotein amount,RS:0000229,DA.PVG.1AV1-(D4Rat63-D4Rat203),both,180 days to 120 days,10,,CMO:0001466,serum orosomucoid 1 level,,,,750,mg/l,,,MMO:0000439,radial immunodiffusion assay,,0.0,radial immunodiffusion assay,,,,pristane (150 ul) ,69772,pristane (150 ul) ,